O.H. Frazier

9.3k total citations · 2 hit papers
241 papers, 6.6k citations indexed

About

O.H. Frazier is a scholar working on Surgery, Biomedical Engineering and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, O.H. Frazier has authored 241 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Surgery, 138 papers in Biomedical Engineering and 96 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in O.H. Frazier's work include Mechanical Circulatory Support Devices (135 papers), Cardiac Structural Anomalies and Repair (110 papers) and Transplantation: Methods and Outcomes (48 papers). O.H. Frazier is often cited by papers focused on Mechanical Circulatory Support Devices (135 papers), Cardiac Structural Anomalies and Repair (110 papers) and Transplantation: Methods and Outcomes (48 papers). O.H. Frazier collaborates with scholars based in United States, United Kingdom and Japan. O.H. Frazier's co-authors include Denton A. Cooley, Igor D. Gregorič, Robert March, Branislav Radovančević, Michael S. Sweeney, Keith A. Horvath, Bartley P. Griffith, Joe B. Putnam, J.Michael Duncan and David A. Ott and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

O.H. Frazier

233 papers receiving 6.3k citations

Hit Papers

Intrapericardial Left Ven... 2012 2026 2016 2021 2017 2012 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O.H. Frazier United States 41 4.5k 3.1k 2.6k 1.3k 839 241 6.6k
Hans H. Scheld Germany 45 3.5k 0.8× 1.7k 0.6× 3.5k 1.4× 636 0.5× 1.1k 1.4× 315 6.7k
Valluvan Jeevanandam United States 47 5.2k 1.1× 3.8k 1.2× 3.1k 1.2× 1.8k 1.4× 693 0.8× 307 8.7k
Alain Pavie France 41 3.8k 0.8× 2.6k 0.8× 2.7k 1.0× 1.5k 1.1× 1.6k 1.9× 200 6.1k
Michael Argenziano United States 44 3.5k 0.8× 1.6k 0.5× 3.0k 1.2× 679 0.5× 1.3k 1.5× 196 5.8k
George P. Noon United States 44 4.0k 0.9× 3.0k 1.0× 2.7k 1.0× 988 0.7× 1.3k 1.6× 225 6.9k
Jack G. Copeland United States 41 4.2k 0.9× 1.9k 0.6× 3.4k 1.3× 513 0.4× 824 1.0× 256 6.7k
David C. McGiffin United States 41 3.8k 0.8× 1.5k 0.5× 2.5k 1.0× 413 0.3× 1.2k 1.4× 316 6.0k
William L. Holman United States 39 3.4k 0.8× 2.7k 0.9× 2.3k 0.9× 1.4k 1.1× 701 0.8× 180 5.4k
Ernst Wolner Austria 57 6.6k 1.5× 2.5k 0.8× 4.8k 1.9× 707 0.5× 3.9k 4.6× 536 12.1k
Robert D. Dowling United States 34 2.8k 0.6× 1.2k 0.4× 978 0.4× 336 0.3× 1.4k 1.6× 126 4.5k

Countries citing papers authored by O.H. Frazier

Since Specialization
Citations

This map shows the geographic impact of O.H. Frazier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O.H. Frazier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O.H. Frazier more than expected).

Fields of papers citing papers by O.H. Frazier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O.H. Frazier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O.H. Frazier. The network helps show where O.H. Frazier may publish in the future.

Co-authorship network of co-authors of O.H. Frazier

This figure shows the co-authorship network connecting the top 25 collaborators of O.H. Frazier. A scholar is included among the top collaborators of O.H. Frazier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O.H. Frazier. O.H. Frazier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fraser, Katharine, et al.. (2022). Numerical and Experimental Analysis for a Magnetic Levitation System in a Hemocompatibility Assessment Platform. 2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC). 139. 2282–2285. 1 indexed citations
3.
Baldwin, Andrew C.W., Elena Sandoval, George V. Letsou, et al.. (2015). Surgical approach to continuous-flow left ventricular assist device explantation: A comparison of outcomes. Journal of Thoracic and Cardiovascular Surgery. 151(1). 192–198. 26 indexed citations
4.
Aaronson, Keith D., Scott Silvestry, Simon Maltais, et al.. (2014). Abstract 18793: Patients Awaiting Heart Transplantation on HeartWare Ventricular Assist Device Support for Greater than Two Years. Circulation. 130. 1 indexed citations
5.
Akay, Mehmet H., Igor D. Gregorič, Rajko Radovancevic, William E. Cohn, & O.H. Frazier. (2011). Timely Use of a CentriMag Heart Assist Device Improves Survival in Postcardiotomy Cardiogenic Shock. Journal of Cardiac Surgery. 26(5). 548–552. 19 indexed citations
6.
Goldstein, Daniel J., Simon Maybaum, Thomas E. MacGillivray, et al.. (2010). Abstract 18067: Young Patients With Non-Ischemic Cardiomyopathy Have Higher Likelihood of Left Ventricular Recovery During HeartMate II Support: Data From the Bridge and Destination Therapy Trials. Circulation. 122. 2 indexed citations
7.
Teuteberg, Jeffrey J., Garrick C. Stewart, Mariell Jessup, et al.. (2010). 62: Strategies for LVAD Therapy in INTERMACS: Intent Rate v. Event Rate. The Journal of Heart and Lung Transplantation. 29(2). S26–S27.
8.
Frazier, O.H.. (2008). In Memoriam: Tetsuzo Akutsu 1922–2007. Texas Heart Institute Journal. 35(1). 4–4. 1 indexed citations
9.
Tüzün, Egemen, Jeff L. Conger, Igor D. Gregorič, et al.. (2004). Evaluation of a New Cardiac Recovery System in a Bovine Model of Volume Overload Heart Failure. ASAIO Journal. 50(6). 557–562. 3 indexed citations
10.
Uray, Iván P., John H. Connelly, O.H. Frazier, Heinrich Taegtmeyer, & Peter J. Davies. (2001). Altered expression of tyrosine kinase receptors Her2/neu and GP130 following left ventricular assist device (LVAD) placement in patients with heart failure. The Journal of Heart and Lung Transplantation. 20(2). 210–210. 8 indexed citations
11.
Popović, Zoran, et al.. (2001). Partial Left Ventriculectomy and Limited Heart Transplantation Availability. Journal of Cardiac Surgery. 16(2). 165–169. 8 indexed citations
12.
Taylor, David O., Mark L. Barr, Branislav Radovančević, et al.. (1999). A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus11This study was sponsored by a grant from Fujisawa USA, Deerfield, Illinois.22The authors were working on behalf of the Tacrolimus US Heart Transplant Multicenter Study Group. Other members of the Study Group included (principal investigator listed first): UTAH Cardiac Transplant Program, Salt Lake City, Utah: David O. Taylor, MD, Dale G. Renlund, MD, Abdallah G. Kfoury, MD; St. Luke’s Episcopal Hospital/Texas Heart Institute, Houston, Texas: O. H. Frazier, MD, Branislav Radovancevic, MD, Edward K. Massin, MD; University of Wisconsin Hospitals and Clinics, Madison, Wisconsin: Robert M. Mentzer, Jr., MD, Charles C. Canver, MD, Robert B. Love, MD; Ochsner Medical Foundation, New Orleans, Louisiana: Frank W. Smart, MD, Hector O. Ventura, MD, Dwight D. Stapleton, MD, Mandeep Mehra, MD; University of Southern California, Los Angeles, California: Mark L. Barr, MD, Vaugh A. Starnes, MD; Medical College of Virginia, Richmond, Virginia: David E. Tolman, MD, Albert Guerraty, MD, David Salter, MD; Cleveland Clinic Foundation, Cleveland, Ohio: James B. Young, MD; Data Management and Statistical Coordinating Center-The EMMES Corporation, Potomac, Maryland: Paul VanVeldhuisen, MS, Anne Lindblad, PhD, Anita Yaffe, MSN, MPH.. The Journal of Heart and Lung Transplantation. 18(4). 336–345. 213 indexed citations
13.
Frazier, O.H.. (1997). The development, evolution, and clinical utilization of artificial heart technology. European Journal of Cardio-Thoracic Surgery. 11. S29–S31. 4 indexed citations
14.
Horvath, Keith J., Lawrence H. Cohn, Denton A. Cooley, et al.. (1997). Transmyocardial laser revascularization: Results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. Journal of Thoracic and Cardiovascular Surgery. 113(4). 645–654. 224 indexed citations
15.
Ballantyne, Christie M., Bernard Masri, Fred J. Clubb, et al.. (1996). Increased expression of ICAM-1 in a case of accelerated coronary artery disease after heart transplantation.. PubMed. 23(4). 293–5. 4 indexed citations
16.
Kadıpaşaoğlu, Kamuran A., S. Rastegar, Michele Sartori, et al.. (1992). In vitro ablation of human aorta under saline and blood with the holmium:YAG laser. 5. 95–112. 2 indexed citations
17.
Hosenpud, Jeffrey D., Teresa DeMarco, O.H. Frazier, et al.. (1991). Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey.. PubMed. 84(5 Suppl). III338–43. 73 indexed citations
18.
Baldwin, Robert T., J.Michael Duncan, O.H. Frazier, & Susan Wilansky. (1991). Patent foramen ovale: A cause of hypoxemia in patients on left ventricular support. The Annals of Thoracic Surgery. 52(4). 865–867. 46 indexed citations
19.
Reul, George J., Denton A. Cooley, Grady L. Hallman, et al.. (1984). Coronary artery bypass for unsuccessful percutaneous transluminal coronary angioplasty. Journal of Thoracic and Cardiovascular Surgery. 88(5). 685–694. 77 indexed citations
20.
Cooley, Denton A., O.H. Frazier, & B D Kahan. (1982). Cardiac transplantation with the use of cyclosporin a for immunologic suppression.. PubMed Central. 9(3). 247–51. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026